electroCore to Participate in iAccess Alpha Virtual Best Ideas Summer Investment Conference
ROCKAWAY, N.J., June 17, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it will participate in the iAccess Alpha Virtual Best Ideas Summer Investment Conference on June 23-24, 2026. Joshua Lev, Interim President and Chief Financial Officer, will deliver a presentation and host one-on-one investor meetings during the conference.
iAccess Alpha Virtual Best Ideas Summer Investment Conference
Dates: June 23-24, 2026
Presentation Time: Tuesday, June 23 at 1:30 p.m. ET
Webcast: https://www.webcaster5.com/Webcast/Page/3165/54084
For more information about the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2026, or to register and schedule a one-on-one meeting with management, please visit the conference website at https://www.iaccessalpha.com.
About electroCore, Inc.
electroCore, Inc. is a bioelectronic technology company whose mission is to improve health and quality of life through innovative non-invasive bioelectronic technologies. The Company’s two leading prescription products, gammaCore® non-invasive vagus nerve stimulation (nVNS) and Quell® neurostimulator, treat chronic pain syndromes through non-invasive neuromodulation technology. Additionally, the company commercializes its handheld, and personal use Truvaga™ and TAC-STIM™ nVNS products utilizing bioelectronic technologies to promote general wellness and human performance.
For more information, visit www.electrocore.com.
Contact:
ECOR Investor Relations
(973) 302-9253
investors@electrocore.com
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
